Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Aeglea BioTherapeutics Inc. logo

Aeglea BioTherapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

Optionable: Yes  Market Cap: 8 M  90-day average vol: 782,418

Previous close: 0.126  Open: 0.129  Bid: 0.1303  Ask: 0.1345
52 week range    
Last updated: Thursday 8th June 2023
MarketXLS Rank

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord


AGLE Income Statement

Invalid dateDec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
Basic EPS total-0.99
Basic weighted shares outstanding10 M15 M21 M32 M53 M66 M84 M
Depreciation-132000.0-249000.0-293000.0-400000.0-996000.0-2 M-2 M
DepreciationAndAmortization-132000.0-249000.0-293000.0-400000.0-996000.0-2 M-2 M
Diluted EPS total-2.22-1.8-2.13-2.45-1.52-1.0-0.99
Diluted weighted shares outstanding84 M
Earnings from equity interest0.0-81 M-66 M-84 M
EarningsFromEquityInterestNetOfTax0.0-81 M-66 M-84 M
GeneralAndAdministrativeExpense8 M10 M13 M16 M22 M27 M29 M
Gross operating profit5 M5 M4 M19 M2 M
Income before tax-22 M-27 M-44 M-78 M-81 M-66 M-84 M
Income taxes-333000.0-296000.0-264000.0-482000.0141000.0-136000.0
Net income from total operations-22 M-27 M-44 M-78 M-81 M-66 M-84 M
NetIncomeCommonStockholders-22 M-27 M-44 M-78 M-81 M-66 M-84 M
NetIncomeContinuousOperations-22 M-27 M-44 M-78 M-81 M-66 M-84 M
NetNonOperatingInterestIncomeExpense244000.0482000.01 M2 M593000.0111000.0837000.0
Operating income-22 M-28 M-45 M-80 M-81 M-66 M-85 M
Operating income before depreciation (EBITDA)-22 M-27 M-46 M-81 M-80 M-64 M-84 M
OperatingExpense-27 M-33 M-49 M-80 M-81 M-84 M-87 M
OperatingRevenue5 M5 M4 M19 M2 M
Other income net36000.042000.057000.063000.05000.0122000.07000.0
OtherGandA8 M10 M13 M16 M22 M27 M29 M
OtherOperatingExpenses-946000.0-1 M-991000.0-910000.0
RentAndLandingFees8 M10 M13 M16 M22 M27 M29 M
Research & development expense18 M23 M37 M65 M60 M57 M59 M
ResearchExpense18 M23 M37 M65 M60 M57 M59 M
SalariesAndWages0.0-5 M-6 M
Selling Gen & administrative expense8 M10 M13 M16 M22 M27 M29 M
Total Income available for interest expense (EBIT)-22 M-28 M-46 M-80 M-81 M-66 M-85 M
Total common shares outstanding13 M17 M29 M29 M48 M65 M
Total net income-22 M-27 M-44 M-78 M-81 M-66 M-84 M
Total ordinary shares65 M65 M65 M65 M65 M65 M65 M
Total revenues5 M5 M4 M19 M2 M
TotalExpenses-27 M-33 M-49 M-80 M-81 M-84 M-87 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and starter sheets.
Get started today